- Research works
- 92 ▲ 21% vs 2013–17
- Citations
- 1.8k 19.4 per fractional work
- Top-10% rate
- 33.1% record average 16.5%
- Open access
- 56% world 28%
Not ranked overall: Celerion (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 13.2×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 13.2×
- Immunology and Microbiology 7.3×
- Medicine 3.2×
- Nursing 2.8×
- Biochemistry, Genetics and Molecular Biology 2.7×
- Veterinary 2.4×
- Economics, Econometrics and Finance 1.3×
- Neuroscience 1.2×
- Chemistry 1.1×
- Dentistry 0.7×
- Psychology 0.3×
- Computer Science 0.2×
- Mathematics 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
Who are the top researchers at Celerion (United States)?
Ranked on the composite score, Edmund Venables lead among researchers whose main affiliation is Celerion (United States).
- 1 Edmund Venables United States · #735,453 worldwide 1 citations · 48 works
Which keywords describe research at Celerion (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Antiretroviral Therapy, Arrhythmias, Ion Channels, Epidemiology, Cardiovascular Disease, Sudden Cardiac Death, Calcium Signaling and Monoclonal Antibodies.
- Cognitive Function
- Virtual Screening
- HIV
- Medicinal Chemistry
- Biosimilars
- Vaccine
- Immunogenicity
- Metabolic Syndrome
- Integrase Inhibitors
- Smoking Cessation
- Insulin Resistance
- Hepatotoxicity
- Long-QT Syndrome
- Psychiatric Disorders
- Pharmacokinetics
- HIV Infection
- Calcium Signaling
- Inflammation
- Arrhythmias
- Antiretroviral Therapy
- Epidemiology
- Cardiovascular Disease
- Ion Channels
- Sudden Cardiac Death
- Monoclonal Antibodies
- Immune Response
- Cancer Risk
- Cardiac Electrophysiology
- Treatment
- Health Consequences
- Drug Resistance
- Tobacco Use
- Nucleoside Analogues
- Biopharmaceuticals
- Genetic Variation
- Bioanalytical Methods
- Heart Failure
- Crystal Structure
- Molecular Docking
- Chronic Kidney Disease
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology8▲ 2.2×31 topics
- Antiretroviral Therapy6▲ 28×5 topics
- Cardiovascular Disease5▲ 5.0×16 topics
- Arrhythmias5▲ 37×2 topics
- Ion Channels4▲ 22×4 topics
- Inflammation4▲ 1.90×19 topics
- Sudden Cardiac Death4▲ 37×2 topics
- Calcium Signaling4▲ 33×4 topics
- Monoclonal Antibodies4▲ 29×3 topics
- HIV Infection4▲ 33×2 topics
- Immune Response4▲ 6.6×8 topics
- Pharmacokinetics4▲ 14×4 topics
- Cancer Risk4▲ 15×3 topics
- Psychiatric Disorders4▲ 26×2 topics
- Cardiac Electrophysiology4▲ 51×1 topic
- Long-QT Syndrome4▲ 51×1 topic
- Treatment4▲ 3.0×8 topics
- Hepatotoxicity3▲ 49×2 topics
- Health Consequences3▲ 19×2 topics
- Insulin Resistance3▲ 7.6×7 topics
- Drug Resistance3▲ 11×2 topics
- Smoking Cessation3▲ 101×1 topic
- Tobacco Use3▲ 101×1 topic
- Integrase Inhibitors3▲ 79×1 topic
- Nucleoside Analogues3▲ 79×1 topic
- Metabolic Syndrome3▲ 3.6×9 topics
- Biopharmaceuticals3▲ 44×3 topics
- Immunogenicity3▲ 57×3 topics
- Genetic Variation3▲ 8.9×2 topics
- Vaccine3▲ 7.1×5 topics
- Bioanalytical Methods2▲ 172×1 topic
- Biosimilars2▲ 172×1 topic
- Heart Failure2▲ 5.6×5 topics
- Medicinal Chemistry2▲ 6.7×3 topics
- Crystal Structure2▲ 9.4×2 topics
- HIV2▲ 18×2 topics
- Molecular Docking2▲ 15×1 topic
- Virtual Screening2▲ 31×1 topic
- Chronic Kidney Disease2▲ 8.3×5 topics
- Cognitive Function2▲ 10×2 topics
Which research topics does Celerion (United States) publish most on?
By volume in 2022–2025: Cardiac electrophysiology and arrhythmias, Fibroblast Growth Factor Research, SARS-CoV-2 and COVID-19 Research and Dermatology and Skin Diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 1 works
- 2 Fibroblast Growth Factor Research Molecular Biology 1 works
- 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 4 Dermatology and Skin Diseases Dermatology 0 works
- 5 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
- 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 7 ECG Monitoring and Analysis Cardiology and Cardiovascular Medicine 0 works
- 8 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
- 9 Psoriasis: Treatment and Pathogenesis Immunology 0 works
- 10 Colorectal Cancer Treatments and Studies Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Celerion (United States)'s research output changed?
Output in 2018–2022 was 21% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lincoln
- University of Nebraska–Lincoln
- Entrepreneurial Ecosystems
- University of Nebraska System
- Pacific Engineering (United States)
- Nebraska Wesleyan University
- Nebraska Hematology-Oncology
- Nebraska Game and Parks Commission
- Bryan Health
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.